NEWARK, Calif. (AP) — NEWARK, Calif. (AP) — Protagonist Therapeutics Inc. (PTGX) on Wednesday reported a loss of $34.2 million in its fourth quarter.
On a per-share basis, the Newark, California-based company said it had a loss of 69 cents.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 67 cents per share.
For the year, the company reported a loss of $127.4 million, or $2.60 per share. Revenue was reported as $26.6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTGX at https://www.zacks.com/ap/PTGX
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
